Stem cells provide new tool for studying disease and identifying ALS drugs Results of two studies funded by Project A.L.S. and appearing in today's advance online publication of Nature Neuroscience demonstrate that embryonic stem cells may provide a new tool for studying disease mechanisms and for identifying drugs to slow ALS, also known as Lou Gehrig's disease. view more (2007-04-17)
The Statin Wars: Why AstraZeneca Must Retreat (p 1341) On Thursday 23 October, AstraZeneca, one of the world's largest pharmaceutical companies, will announce its third-quarter financial results. This coincides with a robust editorial in this week's issue of THE LANCET which calls into question AstraZeneca's high-profile marketing of rosuvastatin, a drug launched into the global statin market last... view more... (2003-10-22)
PDAs, more education help doctors follow cholesterol treatment guidelines A new study by researchers at Wake Forest University School of Medicine suggests that patients with high cholesterol receive better care when physicians use a variety of tools to learn and apply a clinical practice guideline for treating the condition. view more (2009-04-23)
